Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system

Chimeric antigen receptor (CAR)-T cell therapy represents a breakthrough for the treatment of hematological malignancies. However, to treat solid tumors and certain hematologic cancers, next-generation CAR-T cells require further genetic modifications to overcome some of the current limitations. Imp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Aine O’Sullivan, Sarah Case, Aisling McCrudden, Emer Hackett, Louise Gallagher, Darren Martin, Gillian P. Johnson, Kirti Mahadik, Thomas Kienzle, Jude Kevin Lim, Aya Nashat, Kartik Srinivasan, Mark W. Lowdell, Lisa O’Flynn, Jamie Frankish
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-03-01
coleção:	Molecular Therapy: Methods & Clinical Development
Assuntos:	CAR-T genetic engineering adoptive cell therapy metabolism cell avidity cell cytotoxicity
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2329050124002055
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!